Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Lim

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The European Respiratory Journal|February 25, 2012
24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroidsJan Lötvall, Eric D Bateman, Eugene R Bleecker, et al.
Thorax|November 21, 2013
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF aloneEric D Bateman, Paul M O'Byrne, William W Busse, et al.
Therapeutic Innovation & Regulatory Science|June 19, 2018
Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and OpportunitiesJessica Lim, Rosalind Walley, Jiacheng Yuan, et al.
European Journal of Haematology|July 15, 2026
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM TrialsFrancesca Palandri, Casey O'Connell, Pankit Vachhani, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 11, 2026
Spleen Volume Reduction and Transfusion Independence With Momelotinib Versus Ruxolitinib and Associated Overall Survival With Momelotinib in JAK Inhibitor-Naive Patients With Myelofibrosis and Anemia: Subgroup Analyses of SIMPLIFY-1Francesca Palandri, Nicolaas P M Schaap, Jerome Rey, et al.
Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The European Respiratory Journal|February 25, 2012
24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroidsJan Lötvall, Eric D Bateman, Eugene R Bleecker, et al.
Thorax|November 21, 2013
Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF aloneEric D Bateman, Paul M O'Byrne, William W Busse, et al.
Therapeutic Innovation & Regulatory Science|June 19, 2018
Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and OpportunitiesJessica Lim, Rosalind Walley, Jiacheng Yuan, et al.
European Journal of Haematology|July 15, 2026
Impact of Hemoglobin Improvement on Survival in Patients With Myelofibrosis and Anemia Treated With Momelotinib in the SIMPLIFY-1 and MOMENTUM TrialsFrancesca Palandri, Casey O'Connell, Pankit Vachhani, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 11, 2026
Spleen Volume Reduction and Transfusion Independence With Momelotinib Versus Ruxolitinib and Associated Overall Survival With Momelotinib in JAK Inhibitor-Naive Patients With Myelofibrosis and Anemia: Subgroup Analyses of SIMPLIFY-1Francesca Palandri, Nicolaas P M Schaap, Jerome Rey, et al.
Journal of Hepatology|August 30, 2024
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis BMaria Buti, Jeong Heo, Yasuhito Tanaka, et al.
Pageof 3